W Scharmann

573 total citations
37 papers, 473 citations indexed

About

W Scharmann is a scholar working on Molecular Biology, Microbiology and Biotechnology. According to data from OpenAlex, W Scharmann has authored 37 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Microbiology and 8 papers in Biotechnology. Recurrent topics in W Scharmann's work include Antimicrobial Peptides and Activities (6 papers), Microbial Metabolism and Applications (4 papers) and Microbial infections and disease research (4 papers). W Scharmann is often cited by papers focused on Antimicrobial Peptides and Activities (6 papers), Microbial Metabolism and Applications (4 papers) and Microbial infections and disease research (4 papers). W Scharmann collaborates with scholars based in Germany. W Scharmann's co-authors include R. Drzeniek, H. Blobel, Allen H. Heller, J. Porstendörfer, F Jacob, M. Frimmer, Jürgen Homann, Ernst Petzinger, F. Lutz and Werner Seeger and has published in prestigious journals such as Infection and Immunity, Toxicon and Naunyn-Schmiedeberg s Archives of Pharmacology.

In The Last Decade

W Scharmann

34 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W Scharmann Germany	12	228	99	89	76	70	37	473
H. Holst Sweden	12	340 1.5×	79 0.8×	87 1.0×	68 0.9×	25 0.4×	23	635
Khampoune Sayasith Canada	14	274 1.2×	118 1.2×	157 1.8×	140 1.8×	45 0.6×	26	826
E Martín Germany	11	330 1.4×	110 1.1×	59 0.7×	137 1.8×	36 0.5×	12	763
Pasquale F. Bartell United States	16	335 1.5×	84 0.8×	81 0.9×	64 0.8×	180 2.6×	33	534
Doreen Hooi United Kingdom	11	429 1.9×	83 0.8×	144 1.6×	120 1.6×	106 1.5×	16	840
John McMichael United States	17	184 0.8×	245 2.5×	89 1.0×	80 1.1×	78 1.1×	41	873
Howard G. Rush United States	12	130 0.6×	121 1.2×	42 0.5×	52 0.7×	35 0.5×	25	405
Matthew J. Duncan United States	8	296 1.3×	55 0.6×	59 0.7×	145 1.9×	33 0.5×	8	726
K. G. Hibbitt United States	18	126 0.6×	118 1.2×	200 2.2×	99 1.3×	17 0.2×	43	935
Peter L. Sadowski United States	6	100 0.4×	133 1.3×	65 0.7×	58 0.8×	44 0.6×	7	411

Countries citing papers authored by W Scharmann

Since Specialization

Citations

This map shows the geographic impact of W Scharmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Scharmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Scharmann more than expected).

Fields of papers citing papers by W Scharmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Scharmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Scharmann. The network helps show where W Scharmann may publish in the future.

Co-authorship network of co-authors of W Scharmann

This figure shows the co-authorship network connecting the top 25 collaborators of W Scharmann. A scholar is included among the top collaborators of W Scharmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Scharmann. W Scharmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blobel, H., et al.. (2010). Untersuchungen über die Antigenstruktur von Pasteurella multocida. Zentralblatt für Veterinärmedizin Reihe B. 17(4). 441–452.

Scharmann, W & Allen H. Heller. (2001). Survival and transmissibility of Pasteurella pneumotropica. Laboratory Animals. 35(2). 163–166. 32 indexed citations

Scharmann, W, et al.. (1995). [Zur ethischen Abwägung von Tierversuchen]. PubMed. 12(3). 159–159. 3 indexed citations

Scharmann, W. (1991). Improved Housing of Mice, Rats and Guinea-pigs: A Contribution to the Refinement of Animal Experiments. Alternatives to Laboratory Animals. 19(1). 108–114. 32 indexed citations

Scharmann, W, et al.. (1980). Production of timed pregnant mice by utilization of the Whitten effect and a simple cage system.. PubMed. 30(2 Pt 1). 206–8. 7 indexed citations

Scharmann, W. (1976). Purification and Characterization of Leucocidin from Pseudomonas aeruginosa. Journal of General Microbiology. 93(2). 292–302. 44 indexed citations

Scharmann, W. (1976). Interaction of purified leukocidin from Pseudomonas aeruginosa with Bovine polymorphonuclear leukocytes. Infection and Immunity. 13(4). 1046–1053. 17 indexed citations

Scharmann, W. (1976). Cytotoxic effects of leukocidin from Pseudomonas aeruginosa on polymorphonuclear leukocytes from cattle. Infection and Immunity. 13(3). 836–843. 38 indexed citations

Frimmer, M. & W Scharmann. (1975). Toxicity of a highly purified leucocidin from Pseudomonas aeruginosa in perfused rat livers. Naunyn-Schmiedeberg s Archives of Pharmacology. 288(2-3). 123–132. 10 indexed citations

10.

Scharmann, W & W Kraft. (1974). Hemmung der Blutgerinnung in vitro durch Protease vonPseudomonas aeruginosa. Annals of Hematology. 28(2). 90–99. 2 indexed citations

11.

Scharmann, W, et al.. (1974). [The estimation of the molecular weight of bacterial neuraminidases by gel-filtration (author's transl)].. PubMed. 229(1). 55–67. 4 indexed citations

12.

Scharmann, W, et al.. (1974). [Studies on a protease (elastase) from pseudomonas aeruginosa, II: Characterization of the enzyme (author's transl)].. PubMed. 355(8). 958–68. 3 indexed citations

13.

Scharmann, W, et al.. (1974). Untersuchungen an einer Protease (Elastase) ausPseudomonas aeruginosa,II. Charakterisierung des Enzyms. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 355(2). 958–968. 5 indexed citations

14.

Blobel, H., et al.. (1974). [Possible use of pyocins against Pseudomonas aeruginosa (author's transl)].. PubMed. 229(2). 205–8. 1 indexed citations

15.

Jacob, F, H. Blobel, & W Scharmann. (1973). [Typing of Pseudomonas aeruginosa by means of titrated pyocines (author's transl)].. PubMed. 224(4). 472–7. 2 indexed citations

16.

Drzeniek, R., et al.. (1972). Neuraminidase and N-Acetylneuraminate Pyruvate-Lyase of Pasteurella multocida. Journal of General Microbiology. 72(2). 357–368. 33 indexed citations

17.

Scharmann, W. (1972). [Elastase in pseudomonas and aeromonas].. PubMed. 220(1). 435–42. 7 indexed citations

18.

Scharmann, W, et al.. (1971). Wirkung bakterieller neuraminidasen auf transferrin vom menschen, rind und kaninchen. Biochimica et Biophysica Acta (BBA) - Protein Structure. 229(1). 136–142. 6 indexed citations

19.

Scharmann, W & H. Blobel. (1970). [Characterization of nucleases of Staphylococcus aureus].. PubMed. 212(2). 482–5. 1 indexed citations

20.

Scharmann, W, R. Drzeniek, & H. Blobel. (1970). Neuraminidase of Pasteurella multocida. Infection and Immunity. 1(3). 319–320. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact